Edgewise Therapeutics (EWTX) Total Liabilities (2020 - 2026)
Edgewise Therapeutics (EWTX) posted Total Liabilities of $25.3 million for Q1 2026, down 16.57% sequentially from $30.3 million in Q4 2025, and up 2.62% YoY from $24.7 million in Q1 2025.
Edgewise Therapeutics (EWTX) Total Liabilities (2020 - 2026) Analysis & Trends
Edgewise Therapeutics has reported Total Liabilities for 7 years, with the latest figure at $25.3 million in Q1 2026.
- Quarterly Total Liabilities rose 2.62% year-over-year to $25.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.3 million (up 2.62% YoY) and the FY2025 annual result came in at $30.3 million, up 9.95% from the prior year.
- Total Liabilities fell to $25.3 million in Q1 2026 per EWTX's latest filing, from $30.3 million in the prior quarter.
- Over five years, Total Liabilities peaked at $30.3 million in Q4 2025 and troughed at $11.0 million in Q2 2022.
- A 5-year average of $21.1 million and a median of $21.2 million in 2024 frame the typical range for Total Liabilities.
- The widest YoY moves for Total Liabilities: up 87.88% in 2022, down 96.36% in 2022.
- Over 5 years, Total Liabilities stood at $20.4 million in 2022, then gained by 4.02% to $21.2 million in 2023, then jumped by 30.16% to $27.6 million in 2024, then grew by 9.95% to $30.3 million in 2025, then decreased by 16.57% to $25.3 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $25.3 million, $30.3 million, and $24.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Edgewise Therapeutics | 4.76 Bn | 4.76 Bn | - | 31.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 31.61 Mn |
| Mar 31, 2026 | 25.32 Mn |
| Dec 31, 2025 | 30.35 Mn |
| Sep 30, 2025 | 24.82 Mn |
| Jun 30, 2025 | 24.26 Mn |
| Mar 31, 2025 | 24.67 Mn |
| Dec 31, 2024 | 27.60 Mn |
| Sep 30, 2024 | 22.41 Mn |
| Jun 30, 2024 | 21.17 Mn |
| Mar 31, 2024 | 18.87 Mn |
| Dec 31, 2023 | 21.21 Mn |
| Sep 30, 2023 | 20.94 Mn |
| Jun 30, 2023 | 19.17 Mn |
| Mar 31, 2023 | 17.56 Mn |
| Dec 31, 2022 | 20.39 Mn |
| Sep 30, 2022 | 15.75 Mn |
| Jun 30, 2022 | 11.04 Mn |
| Mar 31, 2022 | 12.39 Mn |
| Dec 31, 2021 | 10.85 Mn |
| Sep 30, 2021 | 9.05 Mn |